Showing results (81-90 of 203) with videos related to

Sort By:
Pageof 21
Annals of Hematology|May 18, 2013
Combined use of WT1 and flow cytometry monitoring can promote sensitivity of predicting relapse after allogeneic HSCT without affecting specificityXiao-su Zhao, Chen-hua Yan, Dai-hong Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 4, 2009
[A comparative study on early toxicity of conditioning regimen with or without antithymocyte globulin]Dai-hong Liu, Jing Liu, Kai-yan Liu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 17, 2020
[Clinical Significance of Serum Immunoglobulin Level after Peri- pheral Blood Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies]Tao Lin, Shu Fang, Fei-Yan Wang, et al.
Clinical Transplantation|March 22, 2012
Modified donor lymphocyte infusion-associated acute graft-versus-host disease after haploidentical T-cell-replete hematopoietic stem cell transplantation: incidence and risk factorsChen-Hua Yan, Dai-Hong Liu, Lan-Ping Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 22, 2014
Superior survival of unmanipulated haploidentical hematopoietic stem cell transplantation compared with chemotherapy alone used as post-remission therapy in adults with standard-risk acute lymphoblastic leukemia in first complete remissionChen-Hua Yan, Qian Jiang, Jing Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 13, 2011
[A comparative study of different intervention regimens for chronic myelogenous leukemia post allogeneic hematopoietic stem cell transplantation]Lan-Ping Xu, Dai-Hong Liu, Kai-Yan Liu, et al.
Blood|February 17, 2012
Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantationChen-Hua Yan, Dai-Hong Liu, Kai-Yan Liu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|January 6, 2005
[Multiple factors in erythrocytic recovery following ABO-incompatible allogeneic HSCT]Xiao-Jun Huang, Dai-Hong Liu, Lan-Ping Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 14, 2006
[Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation]Xiao-jun Huang, Dai-hong Liu, Lan-ping Xu, et al.
Zhonghua Yi Xue Za Zhi|July 21, 2005
[Methotrexate for treatment of graft versus host disease after allogeneic hematopoietic stem cell transplantation]Xiao-jun Huang, Qian Jiang, Huan Chen, et al.
Pageof 21